ESPR logo

ESPR
Esperion Therapeutics Inc.

9,098
Mkt Cap
$805.76M
Volume
3.28M
52W High
$4.18
52W Low
$0.8073
PE Ratio
-30.24
ESPR Fundamentals
Price
$3.14
Prev Close
$3.13
Open
$3.14
50D MA
$2.62
Beta
1.53
Avg. Volume
7.79M
EPS (Annual)
-$0.1091
P/B
-2.62
Rev/Employee
$1.37M
$1,149.25
Loading...
Loading...
News
all
press releases
ESPR Stock Surges 44% in a Month: Here's What You Need to Know
Esperion shares jump nearly 44% in a month. The primary catalyst was Archimed's agreement to acquire the company in a deal valued at up to $1.1 billion, including milestone payments.
Zacks
News Placeholder
More News
News Placeholder
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESPR, SILA, CRBG, and EQH
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESPR, SILA, CRBG, and EQH SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESPR, SILA, CRBG, and EQH PR Newswire NEW YORK, May 6, 2026 NEW YORK, May 6, 2026 /PRNewswire/ -- Class...
PR Newswire
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Receives "Hold" Rating from Needham & Company LLC
Needham & Company LLC reissued a 'hold' rating on shares of Esperion Therapeutics in a research report on Monday...
MarketBeat
News Placeholder
Are ESPR, GBTG, MDV, ACR Obtaining Fair Deals for their Shareholders?
Are ESPR, GBTG, MDV, ACR Obtaining Fair Deals for their Shareholders? Are ESPR, GBTG, MDV, ACR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 4, 2026 Insiders may stand to...
PR Newswire
News Placeholder
Esperion Therapeutics (NASDAQ:ESPR) Sees Large Volume Increase - What's Next?
Esperion Therapeutics (NASDAQ:ESPR) Sees Large Volume Increase - Should You Buy...
MarketBeat
News Placeholder
Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Esperion Therapeutics, Inc. (NasdaqGM: ESPR) to...
Business Wire
News Placeholder
What's Going On With Esperion Therapeutics Stock On Monday?
Esperion rises on ARCHIMED's $1.1 billion buyout with $3.16 cash per share and CVR-linked milestones tied to future U.S. sales performance.read more...
Benzinga
News Placeholder
Promising Penny Stocks To Watch Today - May 3rd
Esperion Therapeutics, SOBR Safe, JetBlue Airways, BigBear.ai, Lakewood-Amedex Biotherapeutics, Beyond Meat, and Direxion Daily AMD Bear 1X Shares are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small public companiesc...
MarketBeat
News Placeholder
Small Cap Stocks To Follow Now - May 2nd
Inflection Point Acquisition Corp. II, Direxion Daily MU Bull 2X Shares, Cue Biopharma, Esperion Therapeutics, and Akanda are the five Small Cap stocks to watch today, according to MarketBeat's stock...
MarketBeat
News Placeholder
Penny Stocks To Watch Today - May 2nd
Esperion Therapeutics, SOBR Safe, JetBlue Airways, BigBear.ai, Lakewood-Amedex Biotherapeutics, Beyond Meat, and Direxion Daily AMD Bear 1X Shares are the seven Penny stocks to watch today, according...
MarketBeat
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available